Clinical trials for Carcinoma of esophagus
100 recruiting or active trials synced from ClinicalTrials.gov.
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data- ENROLLING BY INVITATIONN/ANCT06990178Adaptive Neoadjuvant Therapy for Esophageal CancerCancer Hospital Chinese Academy of Medical Science, Shenzhen Center · PI: Tao Zhen Yu, MD
- RECRUITINGNCT07464470Comparison of Molecular-Genetic Concordance of the Primary Tumor and Brain Metastases of Gastroesophageal CancersBlokhin's Russian Cancer Research Center · PI: Alexey Tryakin, MD, PhD, professor
- RECRUITINGN/ANCT07307560High-Flow Nasal Cannula for Preventing Hypoxia During Sedated Endoscopy in High-Risk Obstructive Sleep Apnea PatientsZhejiang University
- ENROLLING BY INVITATIONEarly Phase 1NCT07371247Based on ctDNA-MRD Guided Adjuvant Treatment Escalation After Definitive Chemoradiotherapy for Unresectable Locally Advanced Esophageal Squamous Cell Carcinoma: a Study on Safety and EfficacyThe First Affiliated Hospital with Nanjing Medical University
- RECRUITINGPhase 3NCT07217704Using 18F-FAPI PET to Detect Metastatic Disease in Patients That Have Gastric or Esophageal Cancer.SOFIE · PI: Sherly Mosessian, Ph.D
- ACTIVE NOT RECRUITINGPhase 2NCT07339488Intestinal Low-Dose Radiotherapy Plus Immunochemotherapy for Conversion of Borderline Resectable/Unresectable Esophageal Squamous Cell CarcinomaChuangzhen Chen
- RECRUITINGPhase 2NCT07205731Phase II Study Evaluating Safety and Efficacy of Tislelizumab for Elderly Patients Unfit for Chemotherapy, With Advanced Esophageal Squamous-cell CarcinomaUniversity Hospital, Clermont-Ferrand
- RECRUITINGPhase 2NCT07071103Intestinal Low Dose Radiotherapy Combined With Immunotherapy in Immune-resistant Metastatic Malignant Solid TumorsChuangzhen Chen
- RECRUITINGPHASE1, PHASE2NCT07108855Detection of Upper Gastrointestinal Tumour Depth and Demarcation Using Systemic Administration of Indocyanine Green During Endoscopic Submucosal DissectionUniversity Medical Center Groningen
- RECRUITINGPhase 2NCT07266480Clinical Study of Adbelimumab in the Adjuvant Treatment of Esophageal Squamous Cell Carcinoma.Hebei Medical University Fourth Hospital
- RECRUITINGPhase 2NCT07152678Brachytherapy With Radiotherapy and Immunotherapy: Guided HDR Trial in Esophageal Squamous Cell CarcinomaNational Taiwan University Hospital · PI: Yen-Ting Liu, MD
- RECRUITINGPhase 2NCT07039526Single Dose Investigator Initiated Pilot Study to Investigate CYTALUX (Pafolacianine) for Intraoperative Detection of Malignant Tissue in Subjects Undergoing Surgical Resection for Cancer.John Waters · PI: John Waters, M.D.
- RECRUITINGN/ANCT06523374A Study of Barrett's Esophagus Patients to Investigate Quality of Life and Fear of Cancer, and Optimize a Risk Model Based on Biomarkers and New Technologies to Better Predict the Development of CancerUniversity Hospital, Antwerp · PI: Sheila Krishnadath
- ACTIVE NOT RECRUITINGPhase 2NCT07142421A Study of Trifluridine/Tipiracil Combined With Anlotinib as Second-line Treatment for Recurrent and Metastatic Esophageal Squamous Cell CarcinomaFirst Affiliated Hospital of Zhejiang University
- RECRUITINGPHASE1, PHASE2NCT0629891664Cu-LNTH-1363S in Patients With Sarcoma or Gastrointestinal Tract CancerLantheus Medical Imaging
- RECRUITINGNCT07354295Integrating Multimodal AI to Predict Treatment Response and Refine Risk Stratification in Esophageal Cancer （Radiogenomics-Esophagus）Shu Peng
- RECRUITINGN/ANCT06872515Impact of Prehabilitation in Oncology Via Exercise- Esophageal (IMPROVE-Esophageal)University of Pittsburgh · PI: Melanie Potiaumpai, PhD, MPH
- RECRUITINGPhase 2NCT06819566Prophylactic Endoscopic Variceal Ligation in Patients With High-risk Esophageal Varices Receiving Atezo/Bev for HCCAsan Medical Center · PI: Jihyun An, MD, PhD
- RECRUITINGNCT06979869Investigating Multigene Methylation Dynamics in Treatment Response Surveillance for Esophageal CarcinomaXijing Hospital
- RECRUITINGNCT06597240Home Monitoring During ChemoradiationUniversity Medical Center Groningen · PI: Rudolf S.N. Fehrmann, MD, PhD
- RECRUITINGPhase 1NCT07001592Intra-tumoral (IT) Injection of vvDD-hIL2-2-RG-1 for Metastatic Gastrointestinal and Peritoneal TumorsAllegheny Singer Research Institute (also known as Allegheny Health Network Research Institute) · PI: Patrick Wagner, MD
- RECRUITINGN/ANCT06746623Nonendoscopic Screening for Barrett's Esophagus in Veterans Without Chronic RefluxLouis Stokes VA Medical Center · PI: Katarina B Greer, MD/MS
- RECRUITINGNCT07054086Patient Derived Organoids (PDOs) to Observe the Clinical Consistency of Personalized Neoadjuvant Therapy for Resectable Esophageal Squamous Cell CarcinomaShanghai Zhongshan Hospital
- RECRUITINGNCT07114627Impact of CES1 Genotype on Capecitabine Exposure in Cancer PatientsErasmus Medical Center
- RECRUITINGPHASE2, PHASE3NCT06782412Multicenter Validation Trial of [18F]AlF-FAPI-74 for PET Imaging of Cancer-associated Fibroblasts Through Fibroblast Activation Protein Inhibitors (FAPI) in Different Tumor TypesKU Leuven
- RECRUITINGNCT07266363Integrated Cf-miRNA and Exosomal miRNA Signature for Early Detection of Esophageal Squamous Cell CarcinomaCity of Hope Medical Center · PI: Ajay Goel, PhD
- RECRUITINGN/ANCT06792786A Multicenter Prospective Study Evaluating Concurrent Chemoradiotherapy Following Induction Immunochemotherapy for Esophageal Cancer Based on Dynamic ctDNA MonitoringThe Central Hospital of Lishui City
- RECRUITINGPHASE2, PHASE3NCT06721520Effectiveness of Methods for Pyloric Drainage in esophagecTomY: Botox vs. PyloromyotomyThe Cleveland Clinic · PI: Siva Raja, MD
- RECRUITINGNCT07043491Comparison of Endoscopy and Esophagram for the Routine Evaluation of Anastomosis After McKeown EsophagectomySun Yat-sen University · PI: Hong Yang, PhD.
- RECRUITINGNCT06476678Novel Bipolar Radiofrequency Ablation Knife in Esophageal LesionsBaylor College of Medicine
- RECRUITINGNCT06097078Endoluminal Vacuum Therapy to Prevent Anastomotic Leakage After Esophagectomy Due to Esophageal CancerAesculap AG · PI: Dulce Momblán García, Dr.
- RECRUITINGPhase 2NCT06675201Neoantigen Vaccines in Esophageal Squamous Cell CarcinomaSichuan University · PI: zhenyu ding, MD
- RECRUITINGPhase 2NCT06044311Oral TGF-beta Receptor I Inhibitor Vactosertib in SOC Chemoradiotherapy for Esophageal AdenocarcinomaSakti Chakrabarti · PI: Sakti Chakrabarti, MD
- ACTIVE NOT RECRUITINGNCT06335966BEST-RPP Pilot: Screening for Esophageal Cancer in Rural Oregon Without an EndoscopyOHSU Knight Cancer Institute
- RECRUITINGNCT06713993Semmelweis Esophageal Cancer Study: Noninvasive Prognostic Parameters in Patients With Oesophageal and Esophagogastric Junction CancerSemmelweis University
- RECRUITINGPhase 1NCT0641490218F-AraG PET/CT as a Non-Invasive Imaging Biomarker for Chemoradiation Treatment Response in Esophageal CancerM.D. Anderson Cancer Center · PI: Steven Lin, MD
- RECRUITINGNCT06550063HER2 Status in Esophagogastric Adenocarcinoma and Its Associations With Patient's Clinicopathological OutcomesSt. James's Hospital, Ireland · PI: John V Reynolds, MBBCh,MD
- RECRUITINGNCT06558786Registry for Esophageal and Gastroesophageal Junction CancerMemorial Sloan Kettering Cancer Center · PI: Daniela Molena, MD
- RECRUITINGPhase 1NCT06500052A Study of BL-M17D1 in Patients With Locally Advanced or Metastatic HER2 Positive/Lower Expression Gastrointestinal Cancer and Other Solid TumorsSichuan Baili Pharmaceutical Co., Ltd. · PI: Ruihua Xu
- RECRUITINGPhase 2NCT06498752MRD-Guided Consolidation Therapy Following Definitive Radiotherapy in Esophageal CancerCancer Institute and Hospital, Chinese Academy of Medical Sciences
- ENROLLING BY INVITATIONNCT06475196Prospective Cohort Study of Neoadjuvant Therapy With Sintilimab (PD-1 Inhibitor) Combined With Chemotherapy in Resectable ESCCTang-Du Hospital
- RECRUITINGPhase 2NCT06452602Induction Immunochemotherapy Followed by Concurrent Chemoradiotherapy in Patients With ESCC.Tianjin Medical University Cancer Institute and Hospital · PI: Wencheng zhang, M.D.
- ACTIVE NOT RECRUITINGNCT06453031Gastric Ischemic Preconditioning Before EsophagectomyCHU Rennes - Hopital Pontchaillou
- RECRUITINGN/ANCT06354959Prehab for Lung and Esophageal CancerNova Scotia Health Authority
- RECRUITINGNCT06137508Cancer-associated Cachexia in Patients With Incurable Gastroesophageal CancerRigshospitalet, Denmark · PI: Casper Simonsen, PhD
- RECRUITINGNCT07050576Lymph Node Metastasis in Early Esophageal Squamous Cell CarcinomaThe First Affiliated Hospital of Anhui Medical University
- RECRUITINGPhase 2NCT06403878Safety and Efficacy of Neoadjuvant Immunochemotherapy in Elderly Patients With Resectable Esophageal CancerSichuan University
- RECRUITINGN/ANCT06419244Myosteatosis in Oeso-gastric Cancer: Clinical ImpactsCliniques universitaires Saint-Luc- Université Catholique de Louvain · PI: Yannick Deswysen, MD
- ACTIVE NOT RECRUITINGN/ANCT06722300Clinical Study on the Impact of Eradication of Oral Porphyromonas Gingivalis on the Prognosis of Early Esophageal Cancer After ESD SurgeryThe First Affiliated Hospital of Henan University of Science and Technology · PI: Shegan Gao, MD，pHD
- RECRUITINGPhase 2NCT06421376Induction Chemoimmunotherapy Combined With Chemoradiotherapy in Esophageal CancerCancer Institute and Hospital, Chinese Academy of Medical Sciences · PI: Xin Wang
- RECRUITINGPhase 3NCT06339060An Organ Preservation Strategies After Chemoradiotherapy Combined With Immunotherapy for Esophageal Cancer (PALACE3).Ruijin Hospital · PI: Hecheng Li, MD/PHD
- RECRUITINGPhase 2NCT06398405A Phase II Clinical Study of Epigallocatechin-3-gallate in Patients With Esophageal Squamous CancerShandong Cancer Hospital and Institute
- RECRUITINGNCT06361043Conebeam CT-based Online Adaptive Radio-Therapy for Esophageal Cancer (ARTEC)Insel Gruppe AG, University Hospital Bern · PI: Hossein Hemmatazad, MD
- ACTIVE NOT RECRUITINGPhase 2NCT06143748Combination of Cadonilimab and Chemoradiotherapy in Esophageal Cancer (EC-CRT-006)Sun Yat-sen University · PI: Mian Xi, MD
- RECRUITINGPhase 2NCT06408116Predicting Esophageal Cancer Borders Using PET-ImagingUniversity Hospital Heidelberg
- RECRUITINGN/ANCT06365866Evaluate the Efficacy of Adding Intraluminal Brachytherapy After CCRT for Local-regional Thoracic Esophageal Cancer.Taipei Veterans General Hospital, Taiwan · PI: Pin-I Huang, Ph.D
- RECRUITINGPhase 2NCT06304350Pembrolizumab Combined With Preoperative Chemotherapy (Albumin Paclitaxel+Carboplatin) Neoadjuvant Therapy for Resectable Locally Advanced (Stage II/III) Esophageal Squamous Cell CarcinomaTongji University
- RECRUITINGPhase 3NCT06194734A Study of KC1036 Versus Investigator's Choice of Chemotherapy in Patients With Advanced Esophageal CancerBeijing Konruns Pharmaceutical Co., Ltd. · PI: Jing Huang, Ph.D
- RECRUITINGPhase 2NCT06251973A Study of agenT-797 in Combination With Botensilimab, Balstilimab, Ramucirumab, and Paclitaxel for People With Esophageal, Gastric, or Gastro-esophageal Junction CancerMemorial Sloan Kettering Cancer Center · PI: Yelena Janjigian, MD
- RECRUITINGN/ANCT06138223The Effect of exeRcise And Diet on Quality of Life in Patients With Incurable Cancer of Esophagus and Stomach (RADICES)Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) · PI: Hanneke van Laarhoven
- RECRUITINGN/ANCT06081647The Efficacy and Safety of the COMBO Endoscopy Oropharyngeal Airway in Gastrointestinal Endoscopy ProcedureRenJi Hospital
- ACTIVE NOT RECRUITINGPHASE1, PHASE2NCT05964361First-in-human Interleukin-15-transpresenting Wilms' Tumor Protein 1-targeting Autologous Dendritic Cell Vaccination in Cancer PatientsUniversity Hospital, Antwerp · PI: Timon Vandamme, MD
- RECRUITINGPhase 2NCT06084897Radiotherapy in Patients With Metastatic Esophageal Cancer Responding to PD-1 Inhibitor Plus ChemotherapyCancer Institute and Hospital, Chinese Academy of Medical Sciences · PI: Wen-Yang Liu, MD
- RECRUITINGN/ANCT06101277Locally ablatIVe thErapy for oLigo-progressive gastrOintestiNal maliGnancies (LIVELONG)University of California, Davis · PI: Edward Kim, MD, PhD
- RECRUITINGPhase 1NCT06043466A Clinical Trial Targeting CEA Chimeric Antigen Receptor T (CAR-T) for CEA Positive Advanced Malignant Solid TumorsChongqing Precision Biotech Co., Ltd · PI: Ying Yuan, M.D
- RECRUITINGPhase 1NCT05395910Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) and Electrostatic PIPAC (ePIPAC) With Paclitaxel In Patients With Peritoneal CarcinomatosisNational University Hospital, Singapore · PI: Bok Yan Jimmy So, MBChB
- RECRUITINGPhase 2NCT05624099Camrelizumab Combined With Chemoradiotherapy in Advanced Esophageal Cancer.Fujian Cancer Hospital
- RECRUITINGNCT06431100a Single-arm, Single-center, Open Clinical StudyBeijing Geekgene Technology Co., LTD
- RECRUITINGN/ANCT06077981Comparison of 0.4% Hyaluronic Acid Solution Versus Hydroxyethylamide Solution in Submucosal Endoscopic ResectionsInstituto do Cancer do Estado de São Paulo
- RECRUITINGNCT05937477Developing Artificial Intelligence-based Algorism to Predict Side Effects and Symptoms From ChemotherapySehhoon Park
- ENROLLING BY INVITATIONN/ANCT05706025Study to Evaluate EnteroTracker® as a Sampling Method to Screen for Barrett's Esophagus/Esophageal CancerUniversity of Colorado, Denver · PI: Sachin Wani, MD
- RECRUITINGN/ANCT05704530Liquid Biopsies in Esophageal CancerUniversitaire Ziekenhuizen KU Leuven · PI: Jeroen Dekervel, MD
- RECRUITINGPhase 2NCT06410651Nimotuzumab Concurrent With Chemoradiotherapy for Patients With Unresectable Esophageal Squamous Cell CarcinomaCancer Institute and Hospital, Chinese Academy of Medical Sciences
- ACTIVE NOT RECRUITINGPhase 1NCT05667298Organ-Preserving Endoscopic Resection & Adjuvant RADIO-immuno-chemotherapy for Esophageal CancerUniversity of Manitoba · PI: Biniam Kidane
- RECRUITINGNCT05698992Rehabilitation and Recovery for Persons with Esophageal or Gastric CancerRegion Skane
- RECRUITINGNCT05952661Minimally Residual of Esophageal Cancer 001Hebei Medical University Fourth Hospital · PI: Wenbin Shen, PhD
- RECRUITINGNCT06790797Investigating the Biomarkers in Tumor and Peripheral Blood to Evaluate the Efficacy of Cancer Immunotherapy in Chest Cancer PatientsZhao Jun
- RECRUITINGN/ANCT05370144A Study Involving Neoadjuvant Chemoradiotherapy with Hypofractionated Radiotherapy in Patients with Esophageal and Gastroesophageal Junction AdenocarcinomaAHS Cancer Control Alberta
- ACTIVE NOT RECRUITINGPHASE1, PHASE2NCT05438420Oral Axl/Mer/CSF1R Selective Tyrosine Kinase Inhibitor Q702 in Combination With Pembrolizumab in Patients With Selected Advanced Solid TumorsQurient Co., Ltd.
- RECRUITINGPHASE2, PHASE3NCT05504265Perioperative Analgesia Modes in Minimally Invasive EsophagectomyCancer Institute and Hospital, Chinese Academy of Medical Sciences
- RECRUITINGPhase 4NCT06420258Deeper Intubation Make Effects on Cervical Esophageal ESDFujian Provincial Hospital · PI: Wei Liang, MD
- RECRUITINGNCT06515964China Early Esophageal Cancer CohortChanghai Hospital
- RECRUITINGNCT06009705Toripalimab Combined With Radiotherapy and S-1 for Older Patients With Esophageal CancerHebei Medical University Fourth Hospital · PI: Wenbin Shen, PhD
- ACTIVE NOT RECRUITINGPhase 2NCT05520619Combination of Tislelizumab and Chemoradiotherapy in Esophageal Cancer (EC-CRT-002)Sun Yat-sen University · PI: Ruihua Xu, MD
- RECRUITINGPhase 3NCT05547529The Efficacy of Neoadjuvant Chemoradiotherapy in Comparison With Neoadjuvant Chemotherapy in Patients With Resectable Squamous Cell Esophageal CancerBlokhin's Russian Cancer Research Center
- RECRUITINGN/ANCT05431738Anti-Migration System for Anti-reflux Oeso-gastric Stent (ANTIMIG)Société Française d'Endoscopie Digestive
- RECRUITINGPhase 2NCT05507411Watch and Wait for NeoAdjuvant Concurrent Radiochemotherapy Combined With Camrelizumab in Patients With Resectable ESCCZhejiang Cancer Hospital · PI: Qixun Chen
- RECRUITINGPhase 2NCT05490719A Phase II Study of CRT Combined With QL1706 in ESCC PatientsTianjin Medical University Cancer Institute and Hospital
- RECRUITINGNCT05443841Value of Pleural Lavage Cytology in Resectable Esophageal Carcinoma Eastern Cooperative Thoracic Oncology Projects 2005, ECTOP-2005)Fudan University · PI: Haiquan Chen, MD
- RECRUITINGNCT06393140The Study on the Mechanism of Radiotherapy-elicited Immune ResponseFudan University · PI: Kuaile Zhao, MD
- RECRUITINGPhase 3NCT05055648PROton Versus Photon Therapy for Esophageal Cancer - a Trimodality StrategyUniversity of Aarhus · PI: Marianne Nordsmark, Dr.
- RECRUITINGN/ANCT05327517Surgery or Chemoradiotherapy for Cervical Esophageal CancerCancer Institute and Hospital, Chinese Academy of Medical Sciences · PI: Jie He, MD
- ACTIVE NOT RECRUITINGN/ANCT05145647To Observe the Benefit of Adding Brachytherapy After CCRT on Resectable Esophageal Cancer Patients Without SurgeryChang Gung Memorial Hospital · PI: Chen-Kan Tseng, MD
- RECRUITINGPhase 4NCT05183126Pharmacokinetic Study of Skeletal Muscle Area-based Paclitaxel Infusion in Patients With CancerUniversity of Michigan Rogel Cancer Center · PI: Daniel L Hertz, PharmD, PhD
- RECRUITINGPhase 3NCT05188313TRAstuzumab and Pertuzumab for HER2+ Resectable Oesophageal CancerAcademisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
- RECRUITINGPhase 1NCT05143970A Phase 1 First-In-Human Study of the Anti-CD73 IPH5301 Alone or in Combination With Chemotherapy and Trastuzumab in Patients With Advanced Solid TumorsInstitut Paoli-Calmettes · PI: Anthony GONCALVES, MD PhD
- ACTIVE NOT RECRUITINGN/ANCT06997302A Study on the Impact of Intelligent Nutrition Management on Clinical Outcomes in Chemotherapy Patients With Gastrointestinal MalignanciesTianjin Medical University Cancer Institute and Hospital
- RECRUITINGPhase 2NCT06290505A Trial of Palliative Chemotherapy, Radiation and Immune Treatment for Oesophageal Cancer: PALEO StudyAustralasian Gastro-Intestinal Trials Group · PI: Fiona Day, Dr
- RECRUITINGPhase 3NCT05043688Camrelizumab Plus Neoadjuvant Chemotherapy or Chemoradiotherapy Versus Chemoradiotherapy in Resectable ESCC.Zhigang Li · PI: Yang Yang
- RECRUITINGN/ANCT03961945Minimally Invasive Molecular Approaches for the Diagnosis of Barrett's Esophagus and Esophageal AdenocarcinomaMayo Clinic · PI: Prasad G. Iyer, M.D.